Lorelei Mucci is an Associate Professor of Epidemiology at the Harvard School of Public Health and leads the Cancer Epidemiology program at the Dana Farber/Harvard Cancer Center along with Dr. Meir Stampfer. Dr. Mucci is Primary or Co-Investigator on several funded studies looking across the spectrum of prostate cancer incidence, cancer mortality and somatic alterations. The overarching goals of this research are to reduce the mortality and sufferings associated with prostate cancer and improve overall health among men. She collaborates with a renowned group of prostate cancer investigators and clinicians from around the world on a number of groundbreaking studies including: the Nordic Twin Study of Cancer (NorTwinCan), the Transdisciplinary Prostate Cancer Partnership (ToPCaP), and Steps for Prostate Cancer Health and Survival (SPaRTACuS). Dr. Mucci received her doctoral degree in 2003 from the Harvard School of Public Health and completed a post-doctoral fellowship in cancer epidemiology at the Karolinska Institutet, Sweden. She is seen regularly as a media spokesperson discussing prostate cancer challenges and discoveries. Dr. Mucci has recently brought to the public’s attention how coffee may protect men from prostate cancer, the revelation that there is a strong association between the common sexually transmitted infection, Trichomonas vaginalis, and risk of advanced and lethal prostate cancer, and the advantages of routine walking for men diagnosed with prostate cancer. Lorelei Mucci routinely speaks at global conferences, such as the prestigious 2013 Milken Institute Global Conference, which convenes a hundred leaders from the diverse worlds of business, finance, policy, education, health, energy and philanthropy to come up with fresh solutions to the globe's biggest challenges.